1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
UROSCAN and UROSCANSEQ : a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice–from biobank to RNA-sequencing in real time
(
- Contribution to journal › Article
-
Mark
FDG-PET/CT for lymph node staging prior to radical cystectomy
(
- Contribution to journal › Article
- 2022
-
Mark
Complete metabolic response with [18F]fluorodeoxyglucose-positron emission tomography/computed tomography predicts survival following induction chemotherapy and radical cystectomy in clinically lymph node positive bladder cancer
(
- Contribution to journal › Article
- 2020
-
Mark
Preventing Parastomal Hernia After Ileal Conduit by the Use of a Prophylactic Mesh : A Randomised Study
(
- Contribution to journal › Article
- 2019
-
Mark
Who should record surgical complications? Results from a third-party assessment of complications after radical cystectomy
(
- Contribution to journal › Article
- 2018
-
Mark
Diagnostic pathway efficacy for urinary tract cancer : population-based outcome of standardized evaluation for macroscopic haematuria
(
- Contribution to journal › Article
- 2017
-
Mark
Non-muscle-invasive bladder cancer : a vision for the future
(
- Contribution to journal › Scientific review
- 2016
-
Mark
Hexaminolevulinate hydrochloride blue-light flexible cystoscopy in the detection and follow-up of nonmuscle-invasive bladder cancer : Cost consequences during outpatient surveillance in Sweden
(
- Contribution to journal › Article
- 2015
-
Mark
[F-18]Fluorodeoxyglucose - positron emission tomography/computed tomography improves staging in patients with high-risk muscle-invasive bladder cancer scheduled for radical cystectomy
(
- Contribution to journal › Article